259 related articles for article (PubMed ID: 33926529)
1. Ten-eleven translocation protein 1 modulates medulloblastoma progression.
Kim H; Kang Y; Li Y; Chen L; Lin L; Johnson ND; Zhu D; Robinson MH; McSwain L; Barwick BG; Yuan X; Liao X; Zhao J; Zhang Z; Shu Q; Chen J; Allen EG; Kenney AM; Castellino RC; Van Meir EG; Conneely KN; Vertino PM; Jin P; Li J
Genome Biol; 2021 Apr; 22(1):125. PubMed ID: 33926529
[TBL] [Abstract][Full Text] [Related]
2. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated
Ramsawhook A; Lewis L; Coyle B; Ruzov A
Clin Epigenetics; 2017; 9():18. PubMed ID: 28228863
[TBL] [Abstract][Full Text] [Related]
4. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.
Ji C; Nagaoka K; Zou J; Casulli S; Lu S; Cao KY; Zhang H; Iwagami Y; Carlson RI; Brooks K; Lawrence J; Mueller W; Wands JR; Huang CK
FASEB J; 2019 Feb; 33(2):1824-1835. PubMed ID: 30188753
[TBL] [Abstract][Full Text] [Related]
5. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
Wang P; Yan Y; Yu W; Zhang H
Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.
Fujikura K; Alruwaii ZI; Haffner MC; Trujillo MA; Roberts NJ; Hong SM; Macgregor-Das A; Goggins MG; Roy S; Meeker AK; Ding D; Wright M; He J; Hruban RH; Wood LD
J Pathol; 2021 Jul; 254(3):279-288. PubMed ID: 33870509
[TBL] [Abstract][Full Text] [Related]
7. Effects of ten-eleven translocation 1 (Tet1) on DNA methylation and gene expression in chicken primordial germ cells.
Yu M; Li D; Cao W; Chen X; Du W
Reprod Fertil Dev; 2019 Mar; 31(3):509-520. PubMed ID: 30282572
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A
Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592
[TBL] [Abstract][Full Text] [Related]
9. Tet1 and 5-hydroxymethylation: a genome-wide view in mouse embryonic stem cells.
Wu H; Zhang Y
Cell Cycle; 2011 Aug; 10(15):2428-36. PubMed ID: 21750410
[TBL] [Abstract][Full Text] [Related]
10. Role of TET1-mediated epigenetic modulation in Alzheimer's disease.
Armstrong MJ; Jin Y; Vattathil SM; Huang Y; Schroeder JP; Bennet DA; Qin ZS; Wingo TS; Jin P
Neurobiol Dis; 2023 Sep; 185():106257. PubMed ID: 37562656
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells.
Xu Y; Wu F; Tan L; Kong L; Xiong L; Deng J; Barbera AJ; Zheng L; Zhang H; Huang S; Min J; Nicholson T; Chen T; Xu G; Shi Y; Zhang K; Shi YG
Mol Cell; 2011 May; 42(4):451-64. PubMed ID: 21514197
[TBL] [Abstract][Full Text] [Related]
12. [Roles of ten eleven translocation proteins family and 5-hydroxymethylcytosine in epigenetic regulation of stem cells and regenerative medicine].
Zhao JF; Li D; An Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 53(2):420-424. PubMed ID: 33879920
[TBL] [Abstract][Full Text] [Related]
13. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
14. TET enzymes and 5hmC epigenetic mark: new key players in carcinogenesis and progression in gynecological cancers.
Zacapala-Gómez AE; Mendoza-Catalán MA; Antonio-Véjar V; Jiménez-Wences H; Ortíz-Ortíz J; Ávila-López PA; Baños-Hernández CJ; Salmerón-Bárcenas EG
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1123-1134. PubMed ID: 38375718
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of ten-eleven translocation genes in endometrial cancers.
Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
[TBL] [Abstract][Full Text] [Related]
16. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Müller T; Gessi M; Waha A; Isselstein LJ; Luxen D; Freihoff D; Freihoff J; Becker A; Simon M; Hammes J; Denkhaus D; zur Mühlen A; Pietsch T; Waha A
Am J Pathol; 2012 Aug; 181(2):675-83. PubMed ID: 22688054
[TBL] [Abstract][Full Text] [Related]
17. Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.
Cakouros D; Hemming S; Gronthos K; Liu R; Zannettino A; Shi S; Gronthos S
Epigenetics Chromatin; 2019 Jan; 12(1):3. PubMed ID: 30606231
[TBL] [Abstract][Full Text] [Related]
18. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.
Bezerra Salomão K; Cruzeiro GAV; Bonfim-Silva R; Geron L; Ramalho F; Pinto Saggioro F; Serafini LN; Antunes Moreno D; de Paula Queiroz RG; Dos Santos Aguiar S; Cardinalli I; Yunes JA; Brandalise SR; Brassesco MS; Scrideli CA; Gonzaga Tone L
J Neurooncol; 2018 Aug; 139(1):33-42. PubMed ID: 29582271
[TBL] [Abstract][Full Text] [Related]
19. Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.
Bao B; Teslow EA; Mitrea C; Boerner JL; Dyson G; Bollig-Fischer A
Mol Cancer Res; 2020 Dec; 18(12):1803-1814. PubMed ID: 32913111
[TBL] [Abstract][Full Text] [Related]
20. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
